IPO Profile: Spark Therapeutics Inc

The company, backed by Sofinnova and T. Rowe Price among others, raised $161 million in its IPO

1 February 2015•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.